omega-n-methylarginine has been researched along with puromycin in 2 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (puromycin) | Trials (puromycin) | Recent Studies (post-2010) (puromycin) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 5,828 | 1 | 311 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | puromycin (IC50) |
|---|---|---|---|
| 30S ribosomal protein S6 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S7 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L15 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L10 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L11 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L19 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L1 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L20 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L27 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L28 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L29 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L31 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L32 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L33 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L34 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L35 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L36 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S10 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S11 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S12 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S13 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S16 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S18 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S19 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S20 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S2 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S3 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S4 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S5 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S8 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S9 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L13 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L14 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L16 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L23 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S15 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L17 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L21 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L30 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L6 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S14 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S17 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S1 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L18 | Escherichia coli K-12 | 0.9 | |
| Puromycin-sensitive aminopeptidase | Homo sapiens (human) | 6.075 | |
| 50S ribosomal protein L2 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L3 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L24 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L4 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L22 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L5 | Escherichia coli K-12 | 0.9 | |
| 30S ribosomal protein S21 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L25 | Escherichia coli K-12 | 0.9 | |
| 50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, R; Nakaki, T; Nakayama, M; Otsuka, Y | 1 |
| Baylis, C; Erdely, A; Freshour, G | 1 |
2 other study(ies) available for omega-n-methylarginine and puromycin
| Article | Year |
|---|---|
Endothelium-accelerated hyporesponsiveness of norepinephrine-elicited contraction of rat aorta in the presence of bacterial lipopolysaccharide.
Topics: Amino Acid Oxidoreductases; Animals; Aorta; Arginine; Argininosuccinic Acid; Dactinomycin; Endothelium, Vascular; Escherichia coli; In Vitro Techniques; Lipopolysaccharides; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Polymyxin B; Puromycin; Rabbits; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1992 |
Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat.
Topics: Animals; Chronic Disease; Dose-Response Relationship, Drug; Kidney; Kidney Diseases; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitrogen Dioxide; omega-N-Methylarginine; Puromycin; Rats; Rats, Inbred WF; Rats, Sprague-Dawley; Time Factors | 2006 |